From: Tracking of serum lipids from prepuberty to young adulthood: results from the KiGGS cohort study
 | Male (N = 306) | Female (N = 288) | ||||||
---|---|---|---|---|---|---|---|---|
bivariable | multivariable | bivariable | multivariable | |||||
Beta (95% CI) | R2 | Beta (95% CI) | R2 | Beta (95% CI) | R2 | Beta (95% CI) | R2 | |
Baseline total cholesterol | 0.95 (0.70;1.20)*** | 0.53 | 0.85 (0.70;1.00)*** | 0.62 | 0.75 (0.54;0.96)*** | 0.30 | 0.71 (0.54; 0.87)*** | 0.46 |
BMI z-score in childhood | 0.16 (-0.06; 0.38) | 0.03 | 0.08 (0.00;0.15) | 0.05 (-0.09;0.18) |  < 0.01 | 0.03 (-0.07; 0.14) | ||
Difference in BMI z-score to young adulthood | 0.36 (0.14; 0.57)*** | 0.13 | 0.25 (0.15; 0.35)*** | 0.10 (-0.10;0.31) |  < 0.01 | 0.14 (0.04; 0.24)** | ||
Alcohol use in young adulthood |  | 0.06 |  |  |  < 0.01 |  | ||
 No | 0.64 (-0.18; 1.46) |  | 0.44 (0.09; 0.78) | -0.11 (-0.64; 0.42) |  | 0.23 (-0.18; 0.64) | ||
 Moderate | ref |  | ref | ref |  | ref | ||
 At risk | -0.07 (-0.31; 0.16) |  | 0.05 (-0.09; 0.19) | 0.02 (-0.33; 0.37) |  | -0.09 (-0.32; 0.14) | ||
Oral contraceptives use in young adulthood | - | - | - | - | 0.85 (0.56; 1.13)*** | 0.20 | 0.81 (0.57; 1.04)*** |